Clinical Trials Directory

Trials / Completed

CompletedNCT04987164

Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics

Observational Study Evaluating the Number of Symptomatic Cystitis-like Episodes and Urinary Comfort of Women Consuming Cranberry, Cinnamon and Probiotic Strain Extracts

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
CEN Biotech · Industry
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Cranberries are traditionally used for urinary comfort and prevention of urinary disorders of bacterial origin and despite an EFSA opinion invalidating the clinical efficacy of cranberries, its mechanism of action has been several times proposed by the scientific community: it would act by inhibiting the synthesis of P-fimbriae leading to a complete disappearance of these adhesins, and to bacterial-type deformation by lengthening of the cell body. Cinnamon and microbiotic strains could enhance this synergy. This study aims to evaluate the effectiveness of a food supplement based on cranberry, cinnamon and microbiotic strains (Feminabiane CBU) on the symptoms of cystitis, urinary discomfort and the number of cystitis reported by women.

Detailed description

Women who use or not the cranberry, cinnamon, and microbiotic blend are encouraged to complete a 6-month diary in which they report any urinary tract disorders they encounter.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFeminabiane CBUEXTRACTS OF CRANBERRY, CINNAMON AND MICROBIOTIC STRAINS

Timeline

Start date
2021-11-18
Primary completion
2022-08-04
Completion
2022-08-04
First posted
2021-08-03
Last updated
2023-03-02

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04987164. Inclusion in this directory is not an endorsement.